Andrew O'Hagan

Andrew O'Hagan is an experienced scientist specializing in molecular biology and RNA interference. Currently serving as Principal Associate Scientist for the RNAi Platform at City Therapeutics since April 2025, O'Hagan previously held multiple roles at Generation Bio, including Principal Associate Scientist, Senior Associate Scientist, and Associate Scientist from October 2020 to January 2025. Prior to that, O'Hagan worked as a Research Associate and Laboratory Assistant at Rubius Therapeutics from May 2019 to March 2020, and as a Laboratory Technician at Boston Children's Hospital from October 2018 to February 2019. Andrew O'Hagan earned a Bachelor's degree in Biology from the University of Vermont from 2012 to 2017.